Cardiol Therapeutics' flagship pharmaceutical-grade CBD drug, CardiolRx, is currently being tested as a treatment for various forms of heart disease - offering a huge opportunity to help millions of people while translating into a lot of revenue for the company.

You must be a subscriber to view this content. Learn more about NICI Membership here.

Sign In

Enter your details below.